Healthcare -
Biotechnology - NASDAQ - US
$ 493.756
-0.384 %
$ 52.4 B
Market Cap
12.27
P/E
REGN - TOTAL CURRENT ASSETS
Total Current Assets REGN - Regeneron Pharmaceuticals, Inc.
18.7 B
LAST VALUE
-8.04%
2 YEAR CAGR
12.06%
5 YEAR CAGR
22.23%
10 YEAR CAGR